{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T15:19:04Z","timestamp":1792336744019,"version":"4.4.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2004,9,29]],"date-time":"2004-09-29T00:00:00Z","timestamp":1096416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,9,29]],"date-time":"2004-09-29T00:00:00Z","timestamp":1096416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2004,10,1]]},"DOI":"10.1038\/sj.gt.3302364","type":"journal-article","created":{"date-parts":[[2004,9,29]],"date-time":"2004-09-29T07:18:20Z","timestamp":1096442300000},"page":"S10-S17","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":566,"title":["Immune responses to gene therapy vectors: influence on vector function and effector mechanisms"],"prefix":"10.1038","volume":"11","author":[{"given":"N","family":"Bessis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F J","family":"GarciaCozar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-C","family":"Boissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,9,29]]},"reference":[{"key":"BF3302364_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/sj.gt.3302170","volume":"11","author":"CA Schauber","year":"2004","unstructured":"Schauber CA et al. Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro. Gene Therapy 2004; 11: 266\u2013275.","journal-title":"Gene Therapy"},{"key":"BF3302364_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/sj.gt.3302038","volume":"10","author":"H Wakimoto","year":"2003","unstructured":"Wakimoto H et al. Effects of innate immunity on herpes simplex virus and its ability to kill tumor cells. Gene Therapy 2003; 10: 983\u2013990.","journal-title":"Gene Therapy"},{"key":"BF3302364_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/hum.1997.8.1-37","volume":"8","author":"S Worgall","year":"1997","unstructured":"Worgall S et al. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther 1997; 8: 37\u201344.","journal-title":"Hum Gene Ther"},{"key":"BF3302364_CR4","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/sj.cgt.7700391","volume":"8","author":"Y Liu","year":"2001","unstructured":"Liu Y et al. Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector. Cancer Gene Ther 2001; 8: 948\u2013957.","journal-title":"Cancer Gene Ther"},{"key":"BF3302364_CR5","doi-asserted-by":"publisher","first-page":"9655","DOI":"10.1128\/JVI.74.20.9655-9667.2000","volume":"74","author":"Z Zsengeller","year":"2000","unstructured":"Zsengeller Z et al. Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection. J Virol 2000; 74: 9655\u20139667.","journal-title":"J Virol"},{"key":"BF3302364_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1161\/hh0901.089884","volume":"88","author":"S Rafii","year":"2001","unstructured":"Rafii S et al. Infection of endothelium with E1(\u2212)E4(+), but not E1(\u2212)E4(\u2212), adenovirus gene transfer vectors enhances leukocyte adhesion and migration by modulation of ICAM-1, VCAM-1, CD34, and chemokine expression. Circ Res 2001; 88: 903\u2013910.","journal-title":"Circ Res"},{"key":"BF3302364_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1006\/mthe.2001.0330","volume":"3","author":"MA Schnell","year":"2001","unstructured":"Schnell MA et al. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther 2001; 3: 708\u2013722.","journal-title":"Mol Ther"},{"key":"BF3302364_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/43977","volume":"401","author":"S Lehrman","year":"1999","unstructured":"Lehrman S . Virus treatment questioned after gene therapy death. Nature 1999; 401: 517\u2013518.","journal-title":"Nature"},{"key":"BF3302364_CR9","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1128\/JVI.76.9.4580-4590.2002","volume":"76","author":"AK Zaiss","year":"2002","unstructured":"Zaiss AK et al. Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol 2002; 76: 4580\u20134590.","journal-title":"J Virol"},{"key":"BF3302364_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S0006-291X(02)00210-3","volume":"293","author":"K Yasuda","year":"2002","unstructured":"Yasuda K et al. Plasmid DNA activates murine macrophages to induce inflammatory cytokines in a CpG motif-independent manner by complex formation with cationic liposomes. Biochem Biophys Res Commun 2002; 293: 344\u2013348.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF3302364_CR11","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.4049\/jimmunol.161.9.4493","volume":"161","author":"AK Yi","year":"1998","unstructured":"Yi AK, Krieg AM . Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J Immunol 1998; 161: 4493\u20134497.","journal-title":"J Immunol"},{"key":"BF3302364_CR12","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nm0897-849","volume":"3","author":"M Roman","year":"1997","unstructured":"Roman M et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997; 3: 849\u2013854.","journal-title":"Nat Med"},{"key":"BF3302364_CR13","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1002\/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H","volume":"31","author":"A Krug","year":"2001","unstructured":"Krug A et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol 2001; 31: 3026\u20133037.","journal-title":"Eur J Immunol"},{"key":"BF3302364_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ymthe.2003.11.008","volume":"9","author":"A Reyes-Sandoval","year":"2004","unstructured":"Reyes-Sandoval A, Ertl HC . CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses. Mol Ther 2004; 9: 249\u2013261.","journal-title":"Mol Ther"},{"key":"BF3302364_CR15","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/sj.gt.3301942","volume":"10","author":"W Paster","year":"2003","unstructured":"Paster W et al. In vivo plasmid DNA electroporation generates exceptionally high levels of epitope-specific CD8+ T-cell responses. Gene Therapy 2003; 10: 717\u2013724.","journal-title":"Gene Therapy"},{"key":"BF3302364_CR16","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1089\/104303403767740812","volume":"14","author":"AA Coelho-Castelo","year":"2003","unstructured":"Coelho-Castelo AA et al. B-lymphocytes in bone marrow or lymph nodes can take up plasmid DNA after intramuscular delivery. Hum Gene Ther 2003; 14: 1279\u20131285.","journal-title":"Hum Gene Ther"},{"key":"BF3302364_CR17","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1128\/JVI.72.7.6138-6145.1998","volume":"72","author":"N Chirmule","year":"1998","unstructured":"Chirmule N et al. Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J Virol 1998; 72: 6138\u20136145.","journal-title":"J Virol"},{"key":"BF3302364_CR18","doi-asserted-by":"publisher","first-page":"7678","DOI":"10.1128\/JVI.74.16.7678-7682.2000","volume":"74","author":"V Molinier-Frenkel","year":"2000","unstructured":"Molinier-Frenkel V et al. Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes. J Virol 2000; 74: 7678\u20137682.","journal-title":"J Virol"},{"key":"BF3302364_CR19","doi-asserted-by":"publisher","first-page":"11377","DOI":"10.1073\/pnas.95.19.11377","volume":"95","author":"T Kafri","year":"1998","unstructured":"Kafri T et al. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proc Natl Acad Sci USA 1998; 95: 11377\u201311382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302364_CR20","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<964::AID-IMMU964>3.0.CO;2-P","volume":"29","author":"L Zhong","year":"1999","unstructured":"Zhong L et al. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Eur J Immunol 1999; 29: 964\u2013972.","journal-title":"Eur J Immunol"},{"key":"BF3302364_CR21","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1128\/JVI.74.17.8003-8010.2000","volume":"74","author":"Y Zhang","year":"2000","unstructured":"Zhang Y et al. CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells. J Virol 2000; 74: 8003\u20138010.","journal-title":"J Virol"},{"key":"BF3302364_CR22","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1182\/blood-2002-11-3580","volume":"102","author":"M Chiriva-Internati","year":"2003","unstructured":"Chiriva-Internati M et al. Testing recombinant adeno-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma HM1.24. Blood 2003; 102: 3100\u20133107; Epub 2003 Jul 3110.","journal-title":"Blood"},{"key":"BF3302364_CR23","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1089\/10430340260201662","volume":"13","author":"KQ Xin","year":"2002","unstructured":"Xin KQ et al. Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses. Hum Gene Ther 2002; 13: 1571\u20131581.","journal-title":"Hum Gene Ther"},{"key":"BF3302364_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1128\/JVI.75.1.269-277.2001","volume":"75","author":"A Sarukhan","year":"2001","unstructured":"Sarukhan A et al. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors. J Virol 2001; 75: 269\u2013277.","journal-title":"J Virol"},{"key":"BF3302364_CR25","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","volume":"6","author":"N Chirmule","year":"1999","unstructured":"Chirmule N et al. Immune responses to adenovirus and adeno-associated virus in humans. Gene Therapy 1999; 6: 1574\u20131583.","journal-title":"Gene Therapy"},{"key":"BF3302364_CR26","first-page":"496","volume":"3","author":"TA Smith","year":"1996","unstructured":"Smith TA et al. Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector. Gene Therapy 1996; 3: 496\u2013502.","journal-title":"Gene Therapy"},{"key":"BF3302364_CR27","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/sj.gt.3301611","volume":"8","author":"G Cichon","year":"2001","unstructured":"Cichon G et al. Complement activation by recombinant adenoviruses. Gene Therapy 2001; 8: 1794\u20131800.","journal-title":"Gene Therapy"},{"key":"BF3302364_CR28","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/JVI.72.3.2388-2397.1998","volume":"72","author":"H Gahery-Segard","year":"1998","unstructured":"Gahery-Segard H et al. Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. J Virol 1998; 72: 2388\u20132397.","journal-title":"J Virol"},{"key":"BF3302364_CR29","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1089\/10430349950018021","volume":"10","author":"CR O'Riordan","year":"1999","unstructured":"O'Riordan CR et al. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum Gene Ther 1999; 10: 1349\u20131358.","journal-title":"Hum Gene Ther"},{"key":"BF3302364_CR30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<406::AID-JMV22>3.0.CO;2-N","volume":"59","author":"K Erles","year":"1999","unstructured":"Erles K, Sebokova P, Schlehofer JR . Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J Med Virol 1999; 59: 406\u2013411.","journal-title":"J Med Virol"},{"key":"BF3302364_CR31","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1128\/JVI.74.4.1761-1766.2000","volume":"74","author":"M Moskalenko","year":"2000","unstructured":"Moskalenko M et al. Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure. J Virol 2000; 74: 1761\u20131766.","journal-title":"J Virol"},{"key":"BF3302364_CR32","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1128\/jvi.71.8.5932-5941.1997","volume":"71","author":"CL Halbert","year":"1997","unstructured":"Halbert CL et al. Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J Virol 1997; 71: 5932\u20135941.","journal-title":"J Virol"},{"key":"BF3302364_CR33","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm0397-306","volume":"3","author":"KJ Fisher","year":"1997","unstructured":"Fisher KJ et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 1997; 3: 306\u2013312.","journal-title":"Nat Med"},{"key":"BF3302364_CR34","doi-asserted-by":"crossref","first-page":"9446","DOI":"10.1128\/JVI.73.11.9446-9455.1999","volume":"73","author":"SE Beck","year":"1999","unstructured":"Beck SE et al. Repeated delivery of adeno-associated virus vectors to the rabbit airway. J Virol 1999; 73: 9446\u20139455.","journal-title":"J Virol"},{"key":"BF3302364_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/10430349950018995","volume":"10","author":"WD Lo","year":"1999","unstructured":"Lo WD et al. Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. Hum Gene Ther 1999; 10: 201\u2013213.","journal-title":"Hum Gene Ther"},{"key":"BF3302364_CR36","doi-asserted-by":"publisher","first-page":"8446","DOI":"10.1128\/JVI.76.16.8446-8454.2002","volume":"76","author":"MY Mastakov","year":"2002","unstructured":"Mastakov MY et al. Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain. J Virol 2002; 76: 8446\u20138454.","journal-title":"J Virol"},{"key":"BF3302364_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1006\/mthe.2002.0525","volume":"5","author":"V Anand","year":"2002","unstructured":"Anand V et al. A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adeno-associated virus. Mol Ther 2002; 5: 125\u2013132.","journal-title":"Mol Ther"},{"key":"BF3302364_CR38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1023\/B:JOCI.0000019781.64421.5c","volume":"24","author":"V Cottard","year":"2004","unstructured":"Cottard V et al. Immune response against gene therapy vectors: influence of synovial fluid on adeno-associated virus mediated gene transfer to chondrocytes. J Clin Immunol 2004; 24: 162\u2013169.","journal-title":"J Clin Immunol"},{"key":"BF3302364_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1089\/104303403321208961","volume":"14","author":"MP Boyle","year":"2003","unstructured":"Boyle MP et al. Effect of adeno-associated virus-specific immunoglobulin G in human amniotic fluid on gene transfer. Hum Gene Ther 2003; 14: 365\u2013373.","journal-title":"Hum Gene Ther"},{"key":"BF3302364_CR40","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/JVI.73.5.3994-4003.1999","volume":"73","author":"W Xiao","year":"1999","unstructured":"Xiao W et al. Gene therapy vectors based on adeno-associated virus type 1. J Virol 1999; 73: 3994\u20134003.","journal-title":"J Virol"},{"key":"BF3302364_CR41","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1128\/JVI.75.13.6199-6203.2001","volume":"75","author":"M Hildinger","year":"2001","unstructured":"Hildinger M et al. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J Virol 2001; 75: 6199\u20136203.","journal-title":"J Virol"},{"key":"BF3302364_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000040930","volume":"101","author":"M Onodera","year":"1999","unstructured":"Onodera M et al. Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials. Acta Haematol 1999; 101: 89\u201396.","journal-title":"Acta Haematol"},{"key":"BF3302364_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1006\/clim.1999.4724","volume":"92","author":"DG Brockstedt","year":"1999","unstructured":"Brockstedt DG et al. Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration. Clin Immunol 1999; 92: 67\u201375.","journal-title":"Clin Immunol"},{"key":"BF3302364_CR44","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/sj.gt.3302039","volume":"10","author":"JY Sun","year":"2003","unstructured":"Sun JY et al. Immune responses to adeno-associated virus and its recombinant vectors. Gene Therapy 2003; 10: 964\u2013976.","journal-title":"Gene Therapy"},{"key":"BF3302364_CR45","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/sj.gt.3302142","volume":"11","author":"TC Harding","year":"2004","unstructured":"Harding TC et al. Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B. Gene Therapy 2004; 11: 204\u2013213.","journal-title":"Gene Therapy"},{"key":"BF3302364_CR46","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1172\/JCI200316887","volume":"111","author":"F Mingozzi","year":"2003","unstructured":"Mingozzi F et al. Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. J Clin Invest 2003; 111: 1347\u20131356.","journal-title":"J Clin Invest"},{"key":"BF3302364_CR47","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1182\/blood.V97.12.3733","volume":"97","author":"Y Ge","year":"2001","unstructured":"Ge Y et al. Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX. Blood 2001; 97: 3733\u20133737.","journal-title":"Blood"},{"key":"BF3302364_CR48","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1128\/JVI.72.12.9795-9805.1998","volume":"72","author":"CL Halbert","year":"1998","unstructured":"Halbert CL et al. Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J Virol 1998; 72: 9795\u20139805.","journal-title":"J Virol"},{"key":"BF3302364_CR49","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/hum.1998.9.4-477","volume":"9","author":"WC Manning","year":"1998","unstructured":"Manning WC et al. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors. Hum Gene Ther 1998; 9: 477\u2013485.","journal-title":"Hum Gene Ther"},{"key":"BF3302364_CR50","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1172\/JCI2480","volume":"101","author":"XY Song","year":"1998","unstructured":"Song XY et al. Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J Clin Invest 1998; 101: 2615\u20132621.","journal-title":"J Clin Invest"},{"key":"BF3302364_CR51","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.gt.3302144","volume":"11","author":"YC Zhang","year":"2004","unstructured":"Zhang YC et al. Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity. Gene Therapy 2004; 11: 233\u2013240.","journal-title":"Gene Therapy"},{"key":"BF3302364_CR52","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1006\/cyto.2000.0689","volume":"12","author":"T Ritter","year":"2000","unstructured":"Ritter T et al. Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells. Cytokine 2000; 12: 1163\u20131170.","journal-title":"Cytokine"},{"key":"BF3302364_CR53","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1089\/hum.1995.6.10-1291","volume":"6","author":"JS Harms","year":"1995","unstructured":"Harms JS, Splitter GA . Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum Gene Ther 1995; 6: 1291\u20131297.","journal-title":"Hum Gene Ther"},{"key":"BF3302364_CR54","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1128\/JVI.76.2.791-801.2002","volume":"76","author":"JE Rabinowitz","year":"2002","unstructured":"Rabinowitz JE et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 2002; 76: 791\u2013801.","journal-title":"J Virol"},{"key":"BF3302364_CR55","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1182\/blood-2003-08-2954","volume":"103","author":"R Sarkar","year":"2004","unstructured":"Sarkar R et al. Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype. Blood 2004; 103: 1253\u20131260; Epub 2003 Oct 1259.","journal-title":"Blood"},{"key":"BF3302364_CR56","doi-asserted-by":"publisher","first-page":"11854","DOI":"10.1073\/pnas.182412299","volume":"99","author":"GP Gao","year":"2002","unstructured":"Gao GP et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.PG \u2013 11854-9. Proc Natl Acad Sci USA 2002; 99: 11854\u201311859.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302364_CR57","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/S0042-6822(03)00161-2","volume":"311","author":"P Seshidhar Reddy","year":"2003","unstructured":"Seshidhar Reddy P et al. Development of adenovirus serotype 35 as a gene transfer vector. Virology 2003; 311: 384\u2013393.","journal-title":"Virology"},{"key":"BF3302364_CR58","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1146\/annurev.immunol.21.120601.141110","volume":"21","author":"RH Schwartz","year":"2003","unstructured":"Schwartz RH . T cell anergy. Annu Rev Immunol 2003; 21: 305\u2013334.","journal-title":"Annu Rev Immunol"},{"key":"BF3302364_CR59","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ng1095-191","volume":"11","author":"MA Kay","year":"1995","unstructured":"Kay MA et al. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat Genet 1995; 11: 191\u2013197.","journal-title":"Nat Genet"},{"key":"BF3302364_CR60","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1128\/jvi.70.9.6370-6377.1996","volume":"70","author":"Y Yang","year":"1996","unstructured":"Yang Y et al. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J Virol 1996; 70: 6370\u20136377.","journal-title":"J Virol"},{"key":"BF3302364_CR61","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1749-6632.2003.tb06047.x","volume":"987","author":"J Banchereau","year":"2003","unstructured":"Banchereau J et al. Dendritic cells: controllers of the immune system and a new promise for immunotherapy. Ann NY Acad Sci 2003; 987: 180\u2013187.","journal-title":"Ann NY Acad Sci"},{"key":"BF3302364_CR62","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683\u2013765.","journal-title":"Annu Rev Immunol"},{"key":"BF3302364_CR63","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0966-3274(03)00050-9","volume":"11","author":"M Abe","year":"2003","unstructured":"Abe M, Thomson AW . Influence of immunosuppressive drugs on dendritic cells. Transpl Immunol 2003; 11: 357\u2013365.","journal-title":"Transpl Immunol"},{"key":"BF3302364_CR64","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1182\/blood.V95.10.3162","volume":"95","author":"D Rea","year":"2000","unstructured":"Rea D et al. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood 2000; 95: 3162\u20133167.","journal-title":"Blood"},{"key":"BF3302364_CR65","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.coi.2004.01.013","volume":"16","author":"F Macian","year":"2004","unstructured":"Macian F et al. T-cell anergy. Curr Opin Immunol 2004; 16: 209\u2013216.","journal-title":"Curr Opin Immunol"},{"key":"BF3302364_CR66","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/sj.gt.3302205","volume":"11","author":"SN Waddington","year":"2004","unstructured":"Waddington SN et al. Reduced toxicity of F-deficient Sendai virus vector in the mouse fetus. Gene Therapy 2004; 11: 599\u2013608.","journal-title":"Gene Therapy"},{"key":"BF3302364_CR67","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/sj.gt.3301482","volume":"8","author":"Y Chen","year":"2001","unstructured":"Chen Y et al. Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs. Gene Therapy 2001; 8: 1024\u20131032.","journal-title":"Gene Therapy"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302364","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T11:30:13Z","timestamp":1682767813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,29]]},"references-count":67,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2004,10,1]]}},"alternative-id":["BF3302364"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302364","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,29]]},"assertion":[{"value":"29 September 2004","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}